CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Mason Michael EVP, CFO & Treasurer | Sale | −6,162 | $1.20 | $7K | 398,756 |
| 2024-03-01 | Mano Michael SVP, General Counsel&Secretary | Sale | −3,576 | $1.20 | $4K | 277,852 |
| 2024-03-01 | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Sale | −5,109 | $1.20 | $6K | 393,509 |
| 2024-03-01 | Paulson Richard A. President and CEO | Sale | −19,374 | $1.20 | $23K | 1,164,409 |
| 2024-02-29 | Rangwala Reshma EVP & Chief Medical Officer | Sale | −15,667 | $1.17 | $18K | 355,689 |
| 2024-02-29 | Poulton Stuart EVP, Chief Development Officer | Sale | −16,311 | $1.17 | $19K | 335,666 |
| 2024-02-29 | Mason Michael EVP, CFO & Treasurer | Sale | −27,687 | $1.17 | $32K | 404,918 |
| 2024-02-29 | Mano Michael SVP, General Counsel&Secretary | Sale | −16,973 | $1.17 | $20K | 281,428 |
| 2024-02-29 | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Sale | −21,840 | $1.17 | $26K | 398,618 |
| 2024-02-29 | Paulson Richard A. President and CEO | Sale | −80,470 | $1.17 | $94K | 1,183,783 |
| 2024-02-28 | Rangwala Reshma EVP & Chief Medical Officer | Grant or award | +198,959 | 371,356 | ||
| 2024-02-28 | Poulton Stuart EVP, Chief Development Officer | Grant or award | +188,205 | 351,977 | ||
| 2024-02-28 | Mason Michael EVP, CFO & Treasurer | Grant or award | +188,205 | 432,605 | ||
| 2024-02-28 | Mano Michael SVP, General Counsel&Secretary | Grant or award | +147,000 | 298,401 | ||
| 2024-02-28 | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Grant or award | +198,959 | 420,458 | ||
| 2024-02-28 | Paulson Richard A. President and CEO | Grant or award | +442,800 | 1,264,253 | ||
| 2024-02-27 | Mason Michael EVP, CFO & Treasurer | Sale | −2,545 | $1.32 | $3K | 244,400 |
| 2024-02-15 | Poulton Stuart EVP, Chief Development Officer | Sale | −5,748 | $1.33 | $8K | 163,871 |
| 2024-02-15 | Poulton Stuart EVP, Chief Development Officer | Sale | −99 | $1.40 | $139 | 163,772 |
| 2024-02-06 | Mason Michael EVP, CFO & Treasurer | Sale | −4,205 | $1.59 | $7K | 246,945 |
Page 8 of 15 · 287 trades